Cognitive assessment for postmenopausal women and general assessment of their mental health

Psychopharmacology Bulletin

Volumn 34, Issue 3, 1998, Pages 323-326

  Sherwin, Barbara B ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cognition; Depression; Estrogen; Memory; Progestins

Indexed keywords

ESTROGEN; GESTAGEN; STEROID HORMONE;

BRAIN FUNCTION; COGNITION; CONFERENCE PAPER; DEPRESSION; FEMALE; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; MENTAL HEALTH; NEUROPSYCHOLOGICAL TEST; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY; VISUAL MEMORY;

COGNITION; FEMALE; HUMANS; MENTAL HEALTH; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; WOMEN;

EID: 0031766612     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
2. Arafat, ES; Hargrove, JT; Maxson, WS; Desiderio, DM; Wentz, AC; and Andersen, RN. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am. J. Obstet. Gynecol. 159:1203-1209, 1988.
3. Ballinger, CB. Psychiatric aspects of the menopause. Br. J. Psychiatry 156:773-779, 1990.
4. Barrett-Connor, E, and Kritz-Silverstein, D. Estrogen replacement therapy and cognitive functions in older women. JAMA 269:2637-2641, 1993.
5. Benton, AL. Revised Visual Retention Test. New York: The Psychological Corporation, 1974.
6. Borkowski, JG; Benton, AL; and Spreen, O. Word fluency and brain damage. Neuropsychologia 5:135-140, 1967.
7. Carlson, L, and Sherwin, BB. Steroid hormones, memory and mood in a healthy elderly population. Psychoneuroendocrinol, in press.
8. Colditz, GA; Hankinson, SE; and Hunter, DJ. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332:1589-1593, 1995.
9. Ditkoff, FC; Crary, WG; Cristo, M; and Lobo, RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet. Gynecol. 78:991-995, 1991.
10. Ettinger, B; Quesenberry, C; Schroeder, DA; and Friedman, G. Long-term postmenopausal estrogen therapy may be associated with increased risk of breast cancer: A cohort study. Menopause 4:125-129, 1997.
11. Grodstein, F; Stampfer, MJ; and Colditz, GA. Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336:1769-1775, 1997.
12. Hampson, E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinol. 15:97-111, 1990.
13. Hay, AG; Bancroft, J; and Johnstone, EC. Affective symptoms in women attending a menopause clinic. Br. J. Psychiatry 164:513-516, 1994.
14. Kampen, D, and Sherwin, BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet. Gynecol. 83:979-983, 1994.
15. Luine, V; Park, D; Joh, R; Reis, D; and McEwen, BS. Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Res. 191:273-277, 1980.
16. National Institutes of Health. Chartbook on Cardiovascular, Lung, and Blood Diseases. Washington, DC: U.S. Department of Health and Human Services, May 1992.
17. Phillips, S, and Sherwin, BB. Effects of estrogen on memory functioning in surgically menopausal women. Psychoneuroendocrinol. 17:485-495, 1992.
18. Resnick, SM; Metter, J; and Zonderman, AB. Estrogen replacement therapy and longitudinal decline in visual memory. Neurology 49:1491-1497, 1997.
19. Riis, BJ; Thomsen, K; Strom, V; and Christiansen, C. The effect of percutaneous estradiol and natural progesterone on bone loss. Am. J. Obstet. Gynecol 156:61-65, 1987.
20. Sherwin, BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinol. 13:345-357, 1988.
21. Sherwin, BB. Estrogen and refractory depression. In: Amsterdam, JD, ed. Refractory Depression: Advances in Neuropsychiatry and Psychopharmacology, Volume 2. New York: Raven Press, 1991a. pp. 209-218.
22. Sherwin, BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 72:336-343, 1991b.
23. Sherwin, BB, and Phillips, S. Estrogen and cognitive functioning in surgical menopausal women. Ann. N.Y. Acad. Sci. 592:474-476, 1990.
24. Stampfer, MJ, and Grodstein, F. Role of hormone replacement therapy in cardiovascular disease. In: Lobo, RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven Press, 1994. pp. 223-234.
25. U.S. Bureau of the Census. Projections of the population of the United States: 1977 to 2050. Curr. Pop. Rep. Series P-25, No. 704.
26. Wechsler, D. Manual for the Wechsler Memory Scale - Revised. San Antonio, The Psychological Corporation, 1987.
27. Weiss, NS. Risks and benefits of estrogen use. N. Engl. J. Med. 293:1200-1202, 1975.
28. Woolley, C, and McEwen, BS. Role of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336:293-306, 1993.